APRE Return on Tangible Equity | Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. (APRE) Return on Tangible Equity

2026-06-30: Return Tang Equity -31.99%.
2026-03-31: Return Tang Equity -28.75%.
2025-12-31: Return Tang Equity -101.27%.
2025-09-30: Return Tang Equity -119.48%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-31.99%
2026-03-31	-28.75%
2025-12-31	-101.27%
2025-09-30	-119.48%
2025-06-30	-103.25%
2025-03-31	-90.56%
2024-12-31	-67.12%
2024-09-30	-61.54%
2024-06-30	-50.58%
2024-03-31	-43.97%
2023-12-31	-84.27%
2023-09-30	-65.48%
2023-06-30	-60.23%
2023-03-31	-412.00%
2022-12-31	-439.34%
2022-09-30	-443.10%
2022-06-30	344.91%
2022-03-31	-81.20%
2021-12-31	-74.99%
2021-09-30	-83.80%
2021-06-30	-78.14%
2021-03-31	-77.73%
2020-12-31	-69.10%
2020-09-30	-57.47%
2020-06-30	-45.04%
2020-03-31	-29.98%
2019-12-31	-22.58%
2019-09-30	27.78%
2019-06-30	26.77%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-101.27%
2024-12-31	-67.12%
2023-12-31	-84.27%
2022-12-31	-439.34%
2021-12-31	-74.99%
2020-12-31	-69.10%
2019-12-31	-22.58%
2018-12-31	30.19%
2017-12-31	42.47%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Medicus Pharma Ltd. (MDCX)		$0.010B
Azitra, Inc. (AZTR)	United States	$0.010B	-0.81
FibroBiologics, Inc. (FBLG)	United States	$0.009B	-0.27
Alzamend Neuro, Inc. (ALZN)	United States	$0.009B
Theriva Biologics, Inc. (TOVX)	United States	$0.011B
Traws Pharma, Inc. (TRAW)	United States	$0.009B	-0.58
KALA BIO, Inc. (KALA)	United States	$0.011B	-3.33
MetaVia Inc. (MTVA)	United States	$0.011B	-0.65
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56